Log in

Start free trial
Home 5 Lab Industry Advisor 5 Lab Compliance Advisor 5 CLIA-lca 5 Next Steps: With LDT Final Rule Now Null, Industry Groups Urge Lab Managers and Pathologists to Advocate for Change

Next Steps: With LDT Final Rule Now Null, Industry Groups Urge Lab Managers and Pathologists to Advocate for Change

by | Apr 30, 2025 | CLIA-lca, CLIA-nir, Compliance-lca, Essential, FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor, Labs in Court-lca, Labs in Court-nir, LDTs-lir

CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight

With a judge having vacated the LDT final rule, CAP and AMP officials promote future advocacy as a next step.
iStock, baona

Sign up for our free weekly Lab & Pathology Insider email newsletter

Subscribe to view Essential

Start a Free Trial for immediate access to this article

TRY FOR FREE